greeksoup/ stock research

Metlife (MET) FY2018 results: revenue $67.9 billion, up 9.0% on the year

Metlife Inc. (MET) reported revenue of $67.9 billion for fiscal 2018, the year ended 31 December 2018, up 9.0% on the year before. Net income was $5.1 billion, up 27.8%, and diluted earnings per share $4.91. The figures are the company's own, from the 10-K it filed with the SEC on 22 February 2019.

Revenue
$67.9 billion
+9.0% on the year
FY2011FY2018
Operating margin
9.3%
5.7% a year earlier
FY2011FY2018
Net income
$5.1 billion
+27.8% on the year
FY2011FY2018
Diluted EPS
$4.91
+35.6% on the year
FY2011FY2018

this yearthe year beforeHover a bar for its figure.

The year in brief

Income statement (profit and loss)

$ millionFY2018FY2017FY2016On the yearLast 8 years
Revenue67,94162,30860,787+9.0%
Operating income6,3073,5364,281+78.4%
Operating margin9.3%5.7%7.0%
Interest expense827841874-1.7%
Pre-tax income6,3073,5364,281+78.4%
Income tax1,179-1,470693
Effective tax rate18.7%-41.6%16.2%
Net income5,1234,010850+27.8%
Net margin7.5%6.4%1.4%
Diluted EPS$4.91$3.62$0.63+35.6%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2018FY2017FY2016On the yearLast 8 years
Operating cash flow11,73812,28314,774-4.4%
Cash from investing-5,634-16,876-5,850
Cash from financing-2,801-906-3,497
Depreciation and amortisation238258263-7.8%
Share-based compensation86.0128147-32.8%
Buybacks3,9922,927372+36.4%
Dividends paid1,6781,7171,736-2.3%
Dividend per share$1.66$1.60$1.57+3.7%
Diluted shares, weighted1,014m1,078m1,108m-6.0%
Shares outstanding at period end959m1,044m1,096m-8.1%

Balance sheet

$ millionFY2018FY2017FY2016On the yearLast 8 years
Shareholders' equity52,74158,67667,531-10.1%
Non-controlling interest217194171+11.9%
Redeemable equityn/an/a0.0
Short-term borrowings268477242-43.8%
Debt12,82915,68616,441-18.2%
Other liabilities621,483644,859814,379-3.6%
Total liabilities and equity687,538719,892898,764-4.5%
Goodwill9,4229,5909,220-1.8%
Intangible assets384459509-16.3%
Investments3,9374,8706,523-19.2%
Loans75,45368,21164,601+10.6%
Trading assets12,61616,7450.0-24.7%
Cash and equivalents15,82112,70112,651+24.6%
Other assets569,905607,316805,260-6.2%
Total assets687,538719,892898,764-4.5%

10-K for the year ended 31 December 2018, filed 22 February 2019: the filing.